Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Auro Laboratories Ltd (NSE: AUROLAB), ISIN INE292C01011 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
AUROLAB last traded at ₹228.00 (-0.31%), with a 52-week range of ₹159.00 to ₹317.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 52.40%, FIIs 0.00%, DIIs 0.01%, mutual funds 0.01%.
EquiSense Score (ECS): 68/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.